Schoedel, PhD KA, Rolleri, PharmD RL, Faulknor, MD, CCFP JY, Pixton, MS GC, Chen, PhD N, Bass, PharmD A, Sommerville, MD KW, Sellers, MD, PhD, FRCPC, FACP E. Assessing subjective and physiologic effects following intranasal administration of a new formulation of immediate release oxycodone HCl (Oxecta™) tablets in nondependent recreational opioid users. J of Opioid Management [Internet]. 2012 Sep. 1 [cited 2024 Apr. 27];8(5):315-27. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/693